Oncology-focused CRO running Phase I–III trials and clinical data services
Theradex Oncology is a Princeton-based contract research organization supporting drug sponsors from pre-IND work through Phase III, with oncologists and regulatory specialists on staff. Its job posts point to a full on-prem data center move to AWS, with Terraform and AWS Fargate being adopted and .NET web apps being rebuilt for the cloud. Hiring is accelerating and senior-weighted, led by research roles alongside engineering and clinical positions.
Theradex Oncology is a privately held contract research organization headquartered in Princeton, New Jersey, founded in 1982 and employing 51–200 people. It serves emerging biotech and pharmaceutical sponsors running clinical trials across indications and modalities, and has handled data management and monitoring for studies run through the NCI. Services span regulatory consulting, clinical data management, monitoring, medical writing, biostatistics and programming, pharmacovigilance, quality assurance and clinical technology. Its internal stack combines SAS and Veeva for clinical work with a .NET, Angular and React application layer hosted on AWS and Azure.
Theradex uses SAS and Veeva for clinical operations, plus C#, ASP.NET, Blazor, Angular and React on AWS (ECS, Lambda, RDS, Fargate), with Terraform, Docker, Datadog and Python.
Yes. Job posts describe migrating an entire on-prem data center to AWS and redeveloping on-prem web applications for AWS, with Terraform and AWS Fargate being adopted.
Theradex Oncology is headquartered in Princeton, New Jersey, and currently hires in the United States.
Other companies in the same industry, closest in size
Theradex Oncology's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.